Literature DB >> 22519734

Expression of the polyalanine expansion mutant of nuclear poly(A)-binding protein induces apoptosis via the p53 pathway.

Rumpa Biswas Bhattacharjee1, Thangima Zannat, Jnanankur Bag.   

Abstract

The PABPN1 [nuclear poly(A)-binding protein 1] is ubiquitous, binds to the nascent mRNA transcript and controls the poly(A) tract elongation process in multicellular organisms. Expansion of GCG repeats that encode first 6 of the 10 alanine residues of a polyalanine tract at the N-terminus of wild-type PABPN1 to 12-17 alanine residues causes aggregation of the protein and cell death. Patients with the adult onset autosomal dominant OPMD (oculopharyngeal muscular dystrophy) carry the GCG expansion mutation in their PABPN1 gene. The symptoms of OPMD include drooping eye lids and difficulty swallowing. The severity of symptoms increases with the length of the expansion. We have investigated the mechanism of cell death in HeLa and HEK-293 (human embryonic kidney) cultured cells expressing the mutant PABPN1 with a polyalanine tract containing 17 alanine residues (PABPN1-A17). In cells expressing PABPN1-A17, the abundance of pro-apoptotic proteins, p53, PUMA (p53 up-regulated modulator of apoptosis) and Noxa, are up-regulated. This was associated with the redistribution of p53 to the nucleus and mitochondria. Concomitantly Bax was translocated to the mitochondria, followed by the release of cytochrome c and the cleavage of caspase 3. Furthermore, blocking p53-mediated transcription using pifithrin significantly reduced apoptosis. Our findings suggest a key role of p53-mediated apoptosis in death of cells expressing the polyalanine expansion mutant of PABPN1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22519734     DOI: 10.1042/CBI20110348

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  7 in total

Review 1.  Noxa in rheumatic diseases: present understanding and future impact.

Authors:  Karissa E Cottier; Elise M Fogle; David A Fox; Salahuddin Ahmed
Journal:  Rheumatology (Oxford)       Date:  2013-12-17       Impact factor: 7.580

Review 2.  PABPN1: molecular function and muscle disease.

Authors:  Ayan Banerjee; Luciano H Apponi; Grace K Pavlath; Anita H Corbett
Journal:  FEBS J       Date:  2013-05-24       Impact factor: 5.542

Review 3.  Impaired pre-mRNA processing and altered architecture of 3' untranslated regions contribute to the development of human disorders.

Authors:  Eva Michalova; Borivoj Vojtesek; Roman Hrstka
Journal:  Int J Mol Sci       Date:  2013-07-26       Impact factor: 5.923

4.  A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging.

Authors:  Seyed Yahya Anvar; Yotam Raz; Nisha Verway; Barbara van der Sluijs; Andrea Venema; Jelle J Goeman; John Vissing; Silvère M van der Maarel; Peter A C 't Hoen; Baziel G M van Engelen; Vered Raz
Journal:  Aging (Albany NY)       Date:  2013-06       Impact factor: 5.682

5.  Depletion of nuclear poly(A) binding protein PABPN1 produces a compensatory response by cytoplasmic PABP4 and PABP5 in cultured human cells.

Authors:  Rumpa Biswas Bhattacharjee; Jnanankur Bag
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

6.  Mitochondrion-mediated cell death: dissecting yeast apoptosis for a better understanding of neurodegeneration.

Authors:  Ralf J Braun
Journal:  Front Oncol       Date:  2012-11-28       Impact factor: 6.244

7.  The Inhibition of Heat Shock Protein 90 Facilitates the Degradation of Poly-Alanine Expanded Poly (A) Binding Protein Nuclear 1 via the Carboxyl Terminus of Heat Shock Protein 70-Interacting Protein.

Authors:  Chao Shi; Xuan Huang; Bin Zhang; Dan Zhu; Huqiao Luo; Quqin Lu; Wen-Cheng Xiong; Lin Mei; Shiwen Luo
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.